PRPH Price / Book | ProPhase Labs, Inc.

ProPhase Labs, Inc. (PRPH) Price / Book

2025-12-31: Price/Book Ratio 1.15.
2025-09-30: Price/Book Ratio 27.85.
2025-06-30: Price/Book Ratio 14.17.
2025-03-31: Price/Book Ratio 10.99.

Historical market capitalization divided by filed shareholder equity.

Available history: 2011-09-30 to 2025-12-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2025-12-31	1.15
2025-09-30	27.85
2025-06-30	14.17
2025-03-31	10.99
2024-12-31	3.09
2024-09-30	12.11
2024-06-30	18.09
2024-03-31	26.02
2023-12-31	16.52
2023-09-30	13.97
2023-06-30	20.64
2023-03-31	21.42
2022-12-31	24.53
2022-09-30	26.62
2022-06-30	29.25
2022-03-31	16.31
2021-12-31	18.94
2021-09-30	16.86
2021-06-30	19.68
2021-03-31	21.29
2020-12-31	100.92
2020-09-30	37.31
2020-06-30	15.32
2020-03-31	20.59
2019-12-31	20.3
2019-09-30	15.5
2019-06-30	16.96
2019-03-31	22.15
2018-12-31	22.04
2018-09-30	17.58
2018-06-30	17.62
2018-03-31	10.33
2017-12-31	8.47
2017-09-30	9.44
2017-06-30	7.69
2017-03-31	7.65
2016-12-31	57.3
2016-09-30	51.5
2016-06-30	35.14
2016-03-31	31.91
2015-12-31	29.02
2015-09-30	25.71
2015-06-30	25.66
2015-03-31	22.22
2014-12-31	21.07
2014-09-30	25.64
2014-06-30	20.69
2014-03-31	26.03
2013-12-31	20.31
2013-09-30	25.92
2013-06-30	23.85
2013-03-31	22.36
2012-12-31	17.62
2012-09-30	19.35
2012-06-30	18.27
2012-03-31	13.54
2011-12-31	15.02
2011-09-30	9.23

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xenetic Biosciences, Inc. (XBIO)	United States	$0.006B
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
Pulmatrix, Inc. (PULM)	United States	$0.006B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26